OncClubAll Oncology NewsPipeline Report
InsightsMedical World NewsOncChatsOncLive News Network®OncLive TVPeer ExchangePodcastsRapid ReadoutsThe Talk
Conference CoverageConference Listing
Giants of Cancer CarePER EventsScientific InterchangesState of the Science Summit / IPCWebinars
Partners
Oncology Live®Oncology FellowsSupplements And Featured PublicationsAll Publications
CME/CE
Biomarker ConsortiumInteractive ToolsLearning ModulesPresentationsSponsored
Print SubscriptioneNewsletter
Biosimilars
Brain Cancer
Breast CancerBreast Cancer
Business Management
CAR T-cell Therapy
COVID-19
Disparities in Cancer Care
Gastrointestinal CancerGastrointestinal Cancer
Genitourinary CancersGenitourinary CancersGenitourinary Cancers
Global Oncology
Gynecologic OncologyGynecologic Oncology
Head & Neck Cancers
Hematologic OncologyHematologic OncologyHematologic OncologyHematologic OncologyHematologic OncologyHematologic Oncology
Immuno-OncologyImmuno-OncologyImmuno-OncologyImmuno-Oncology
Lung Cancer
Melanoma & Skin Cancer
Oncology Nursing News
Pediatric Oncology
Precision Medicine in Oncology®Precision Medicine in Oncology®
Sarcomas/TGCT
Supportive Care
Spotlight -
  • REGISTER TODAY to explore data on a novel second-generation BTK inhibitor for adult patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL).
  • Share your views with OncChats
Biosimilars
Brain Cancer
Breast CancerBreast Cancer
Business Management
CAR T-cell Therapy
COVID-19
Disparities in Cancer Care
Gastrointestinal CancerGastrointestinal Cancer
Genitourinary CancersGenitourinary CancersGenitourinary Cancers
Global Oncology
Gynecologic OncologyGynecologic Oncology
Head & Neck Cancers
Hematologic OncologyHematologic OncologyHematologic OncologyHematologic OncologyHematologic OncologyHematologic Oncology
Immuno-OncologyImmuno-OncologyImmuno-OncologyImmuno-Oncology
Lung Cancer
Melanoma & Skin Cancer
Oncology Nursing News
Pediatric Oncology
Precision Medicine in Oncology®Precision Medicine in Oncology®
Sarcomas/TGCT
Supportive Care
    • Partners
    • CME/CE
Advertisement

Management of Myeloproliferative Neoplasms

home / peer-exchange / mpn-management
Advertisement
An Overview of Myeloproliferative Neoplasms

EP. 1: An Overview of Myeloproliferative Neoplasms

July 10th 2018
MPNs: Differentiating Between ET, PV, and MF

EP. 2: MPNs: Differentiating Between ET, PV, and MF

July 10th 2018
Suspecting Polycythemia Vera: Challenges in Diagnosis

EP. 3: Suspecting Polycythemia Vera: Challenges in Diagnosis

July 10th 2018
Polycythemia Vera: Making a Diagnosis

EP. 4: Polycythemia Vera: Making a Diagnosis

July 10th 2018
Polycythemia Vera: Considerations for Frontline Therapy

EP. 5: Polycythemia Vera: Considerations for Frontline Therapy

July 10th 2018
Determining Inadequate Control or Intolerance in PV

EP. 6: Determining Inadequate Control or Intolerance in PV

July 10th 2018
Advertisement
Polycythemia Vera: Controlling HCT and WBC

EP. 7: Polycythemia Vera: Controlling HCT and WBC

July 10th 2018
Selecting Appropriate Therapy at Progression of PV

EP. 8: Selecting Appropriate Therapy at Progression of PV

July 10th 2018
Ruxolitinib's Role in Treating Polycythemia Vera

EP. 9: Ruxolitinib's Role in Treating Polycythemia Vera

July 10th 2018
Optimizing the Use of Ruxolitinib for Polycythemia Vera

EP. 10: Optimizing the Use of Ruxolitinib for Polycythemia Vera

July 10th 2018
Myelofibrosis: Diagnosis and Risk Stratification

EP. 11: Myelofibrosis: Diagnosis and Risk Stratification

July 10th 2018
Ruxolitinib's Role in Treating Myelofibrosis

EP. 12: Ruxolitinib's Role in Treating Myelofibrosis

July 10th 2018
Advertisement
Polycythemia Vera: Novel JAK Inhibitors

EP. 13: Polycythemia Vera: Novel JAK Inhibitors

July 10th 2018
Treating Anemia With Luspatercept in MDS

EP. 14: Treating Anemia With Luspatercept in MDS

July 10th 2018
Determining the Potential of Ropeginterferon Alfa-2b in Polycythemia Vera

EP. 15: Determining the Potential of Ropeginterferon Alfa-2b in Polycythemia Vera

July 10th 2018
Unmet Needs and Future Directions in Treating MPNs

EP. 16: Unmet Needs and Future Directions in Treating MPNs

July 10th 2018

Latest Conference Coverage

Smoldering Multiple Myeloma Management Hinges on the Debate Between Treatment and Observation

Lung Responses to Atezolizumab/Bevacizumab Linked With OS in HCC and Pulmonary Metastasis

Second-Line Regorafenib Demonstrates Safety in Advanced HCC, Irrespective of Prior Treatment

First-line Toripalimab Plus Sorafenib Elicits Responses in Unresectable Hepatocellular Carcinoma

View More Latest Conference Coverage
Advertise
About OncLive
Editorial Board
CancerNetwork.com
CGTlive.com
CureToday.com
OncNursingNews.com
TargetedOnc.com
Contact Us
Privacy
Terms & Conditions
Do Not Sell My Information
Contact Info

2 Clarke Drive
Cranbury, NJ 08512

609-716-7777

© 2023 MJH Life Sciences

All rights reserved.
Home
About Us
News
Contact